BRPF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.251200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.149200E-01
Normal-vs-Stage2
3.499800E-01
Normal-vs-Stage3
2.957900E-03
Normal-vs-Stage4
5.051800E-01
Stage1-vs-Stage2
3.769200E-01
Stage1-vs-Stage3
9.025900E-02
Stage1-vs-Stage4
4.040400E-01
Stage2-vs-Stage3
1.031370E-01
Stage2-vs-Stage4
3.158100E-02
Stage3-vs-Stage4
4.628000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.950200E-01
Normal-vs-AfricanAmerican
9.307400E-01
Normal-vs-Asian
2.604000E-01
Caucasian-vs-AfricanAmerican
1.887380E-01
Caucasian-vs-Asian
8.885800E-01
AfricanAmerican-vs-Asian
4.010800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.730200E-01
Normal-vs-Female
3.849600E-01
Male-vs-Female
6.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.157390E-01
Normal-vs-Age(41-60Yrs)
5.226200E-01
Normal-vs-Age(61-80Yrs)
2.549400E-01
Normal-vs-Age(81-100Yrs)
2.321000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.991400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.360800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.682600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.281500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.819600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.212000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.519600E-01
Normal-vs-Daily Drinker
3.295600E-02
Normal-vs-Weekly Drinker
4.645000E-01
Normal-vs-Occasional Drinker
6.009000E-01
Normal-vs-Social Drinker
6.390800E-01
Non Drinker-vs-Daily Drinker
7.338400E-02
Non Drinker-vs-Weekly Drinker
4.727000E-01
Non Drinker-vs-Occasional Drinker
1.427050E-01
Non Drinker-vs-Social Drinker
2.479800E-01
Daily Drinker-vs-Weekly Drinker
2.845500E-02
Daily Drinker-vs-Occasional Drinker
7.004800E-03
Daily Drinker-vs-Social Drinker
1.025600E-02
Weekly Drinker-vs-Occasional Drinker
5.296600E-01
Weekly Drinker-vs-Social Drinker
7.101600E-01
Occasional Drinker-vs-Social Drinker
7.683200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.340800E-01
Normal-vs-Grade 2
8.164200E-02
Normal-vs-Grade 3
8.447700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.535600E-01
Grade 1-vs-Grade 3
5.453000E-01
Grade 1-vs-Grade 4
1.340800E-01
Grade 2-vs-Grade 3
4.343000E-01
Grade 2-vs-Grade 4
8.164200E-02
Grade 3-vs-Grade 4
8.447700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.978600E-01
Normal-vs-NonDiabetic
3.181000E-01
Diabetic-vs-NonDiabetic
4.849000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.232000E-02
Normal-vs-NoPancreatitis
3.691200E-01
Pancreatitis-vs-NoPancreatitis
8.724500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.312000E-01
Normal-vs-N1
3.366200E-01
N0-vs-N1
5.096400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.026400E-01
Normal-vs-TP53-NonMutant
9.692400E-01
TP53-Mutant-vs-TP53-NonMutant
5.903600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
